|
|
|||
|
||||
OverviewClinical Trials in Osteoporosis is a practical handbook on clinical trials in the growing field of osteoporosis. Topics covered include study design, technical issues, data collection, quality assurance, data analysis and presentation. It aims to take the user through the process step-by-step from start to finish, also providing a background on regulatory guidelines, ethical implications, endpoints, current therapies and the ideal drug to use. There are no other books at present that specifically address the issue of clinical trials in osteoporosis. A number of issues dealt with in this book have been brought together in one publication for the first time. Clinical Trials in Osteoporosis is intended to serve as a practical manual for clinicians and scientists coming to the subject new and to provide a standard for existing centers to measure themselves against. Full Product DetailsAuthor: Derek E. Pearson , Colin G. MillerPublisher: Springer London Ltd Imprint: Springer London Ltd Dimensions: Width: 15.60cm , Height: 1.40cm , Length: 23.40cm Weight: 0.392kg ISBN: 9781852332297ISBN 10: 1852332298 Pages: 271 Publication Date: March 2002 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Paperback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsForeword.- Introduction.-1. Study design and the pre-trial phase: Study design and endpoints. Ethical considerations. Standardisation and pre-trial quality control.-2. Performing the trial: Organisation of the clinical trial by the sponsor. Local organisation. Clinical trial quality assurance. Laboratory and instrument quality control.-3. Data analysis and presentation: Data analysis and presentation: writing a paper for publication.-4. Background: Current and future therapies for osteroporosis. The ideal drug for the treatment of osteoporosis. Instrument measurements in osteoporosis clinical trials: Evaluating the end points. Biochemical markers of bone turnover. Future therapies and clinical trials.-Appendix A: Glossary of terms.-Appendix B: Sample study data.-Index.ReviewsFrom the reviews: This book is a practical bench support for all people involved in clinical research dealing with osteoporosis. The book is well designed, easy to read and easy to address as a reference for all aspects regarding osteoporosis and clinical trials in osteoporosis. The quality control regarding both organizational, technical and clinical aspects up to publication of the results of the trials are thoroughly developed in the book. This book a ] does not really have any counterpart in the available literature on the subject. The target audience of the book appears to be very large a ] and includes industry partners and sponsors, members of CROs and CRAs and monitors, clinical investigators, physicians and technical staff, clinical trial nurses and other members of the non medical staff involved in a trial related to osteoporosis. (Daniel Uebelhart, Zeitschrift fA1/4r Rheumatologie 2003;63(2);208.) This is a practical and well illustrated handbook covering all aspects of clinical trials in the field of osteoporosis. The book is of special interest for everyone planning to conduct research in the specific field of osteporosis. (P. DelincA(c), Acta Orthopaedica Belgica 2005; 71(1),128) This is a practical and well illustrated handbook covering over four chapters all aspects of clinical trials in the field of osteoporosis. a ] The book is of special interest for everyone, planning to conduct research in the specific field of osteoporosis. (P. DelincA(c), Acta Orthopaedica Belgica, Vol. 71 (1), 2005) The a ] book covers all nowadays aspects of performing clinical trials in osteoporosis (OP). a ] This book is a practical bench support for all people involved inclinical research dealing with osteoporosis. The book is well designed, easy to read and easy to address as a reference for all aspects regarding osteoporosis and OP clinical trials. a ] I would strongly recommend the purchase and use of this book which does not really have any counterpart in the available literature on the subject. (Daniel Uebelhart, Zeitschrift fA1/4r Rheumatologie, Vol. 62 (2), 2003) From the reviews: <p>This book is a practical bench support for all people involved in clinical research dealing with osteoporosis. The book is well designed, easy to read and easy to address as a reference for all aspects regarding osteoporosis and clinical trials in osteoporosis. The quality control regarding both organizational, technical and clinical aspects up to publication of the results of the trials are thoroughly developed in the book. This book a ] does not really have any counterpart in the available literature on the subject. The target audience of the book appears to be very large a ] and includes industry partners and sponsors, members of CROs and CRAs and monitors, clinical investigators, physicians and technical staff, clinical trial nurses and other members of the non medical staff involved in a trial related to osteoporosis. (Daniel Uebelhart, Zeitschrift fA1/4r Rheumatologie 2003;63(2);208.) <p>This is a practical and well illustrated handbook covering all aspects of clinical trials in the field of osteoporosis. The book is of special interest for everyone planning to conduct research in the specific field of osteporosis. (P. DelincA(c), Acta Orthopaedica Belgica 2005; 71(1),128) <p> This is a practical and well illustrated handbook covering over four chapters all aspects of clinical trials in the field of osteoporosis. a ] The book is of special interest for everyone, planning to conduct research in the specific field of osteoporosis. (P. DelincA(c), Acta Orthopaedica Belgica, Vol. 71 (1), 2005) <p> The a ] book covers all nowadays aspects of performing clinical trials in osteoporosis (OP). a ] This book is a practical bench support for all people involved inclinical research dealing with osteoporosis. The book is well designed, easy to read and easy to address as a reference for all aspects regarding osteoporosis and OP clinical trials. a ] I would strongly recommend the purchase and use of this book which does not really have any counterpart in the available literature on the subject. (Daniel Uebelhart, Zeitschrift fA1/4r Rheumatologie, Vol. 62 (2), 2003) Author InformationTab Content 6Author Website:Countries AvailableAll regions |
||||